Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 180 DEGREE CAPITAL CORP. /NY/TURN · Entity 75342 | Director | December 31, 2021 | January 03, 2022 |
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Director | June 04, 2022 | June 07, 2022 |
| WisdomTree, Inc.WT · Entity 4093 | Director | June 17, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
180 DEGREE CAPITAL CORP. /NY/
Report date December 31, 2021 · Filed January 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,268 |
Reported balance
After 2021-12-31 transaction · row 1
1 source rowRow 1 · 2021-12-31 · Purchase · Acquired 683 · Balance 4,268 |
LIFECORE BIOMEDICAL, INC. \DE\
Report date June 04, 2022 · Filed June 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,599 |
Reported balance
After 2022-06-04 transaction · row 1
1 source rowRow 1 · 2022-06-04 · Grant · Acquired 7,059 · Balance 59,599 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2022-06-04 | Direct | 0 |
Reported balance
After 2022-06-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-06-04 · Exercise / conversion · Disposed 7,059 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on June 4, 2021. F3: The restricted stock units vested on June 4, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on June 4, 2021.
F3: The restricted stock units vested on June 4, 2022.
WisdomTree, Inc.
Report date June 17, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,471.0051 |
Reported balance
After 2026-06-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 5,509 · Balance 40,471.0051 F1: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 18, 2026 20:26 UTC | WisdomTree, Inc. WT · Entity 4093 | GrantCommon Stock | 5,509 | $0.00 | $0.00 |
DisclosureSEC source: 0001268528-26-000004 · f4_a1eus0000096rm1maa-live.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,471.0051 F1 · balance_after: Includes restricted stock award that vests as to 5,509 shares on June 17, 2027. Read SEC document |
| February 25, 2026 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 44.3439 | $16.94 | $751.40 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 6 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,962.0051 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| November 26, 2025 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 67.7869 | $11.05 | $749.37 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 5 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,917.6612 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| August 27, 2025 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 33.0585 | $13.43 | $443.81 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 4 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,849.8743 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 19:52 UTC | WisdomTree, Inc. WT · Entity 4093 | GrantCommon Stock | 9,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-25-000360 · f4_a1eus000005xzhlmac-live.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,685 F1 · balance_after: Includes restricted stock award that vests as to 9,871 shares on June 17, 2026. Read SEC document |
| May 28, 2025 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 46.0074 | $9.62 | $442.43 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 3 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,816.8158 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| February 26, 2025 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 47.6258 | $9.26 | $441.01 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,770.8084 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| November 20, 2024 Filed Mar 9, 2026 12:58 UTC | WisdomTree, Inc. WT · Entity 4093 | PurchaseCommon Stock | 38.1826 | $11.52 | $439.86 |
DisclosureSEC source: 0001268528-26-000002 · f4_a1eus000008alwdmaw-live.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,723.1826 F1 · shares: Represents shares acquired via dividend reinvestment pursuant to a dividend reinvestment plan sponsored by a broker-dealer. F2 · balance_after: Includes restricted stock awards which vests as to 9,871 shares on June 17, 2026. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:48 UTC | WisdomTree, Inc. WT · Entity 4093 | GrantCommon Stock | 10,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-24-000301 · f4_a1edp0000016qgrmam-live.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,814 F1 · balance_after: Represents restricted stock awards which vest as to (i) 14,662 shares on June 26, 2024 and (ii) 10,152 shares on June 12, 2025. Read SEC document |
| June 26, 2023 Filed Jun 27, 2023 20:44 UTC | WisdomTree, Inc. WT · Entity 4093 | GrantCommon Stock | 14,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001664272-23-000390 · f4_a1e2k00000tmg9duax-live.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,662 F1 · balance_after: Restricted stock award which vests on June 26, 2024. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:15 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016482 · wf-form4_165463652094827.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,059 shares Expires 2022-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 4, 2021. F3 · derivative.exercise_date: The restricted stock units vested on June 4, 2022. F3 · derivative.expiration_date: The restricted stock units vested on June 4, 2022. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:15 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016482 · wf-form4_165463652094827.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,599 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-016012 · wf-form4_165418841024700.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 9,474 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 08:48 UTC | 180 DEGREE CAPITAL CORP. /NY/ TURN · Entity 75342 | PurchaseCommon Stock | 683 | $7.32 | $4,997.58 |
DisclosureSEC source: 0001268528-22-000002 · wf-form4_164121772151337.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 00:03 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 7,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001572 · primary_01.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,059 Underlying: Common Stock · 7,059 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001526 · primary_01.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,303 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2020. F3 · derivative.exercise_date: The restricted stock units vested on June 1, 2021. F3 · derivative.expiration_date: The restricted stock units vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:09 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001526 · primary_01.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,540 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 09:04 UTC | 180 DEGREE CAPITAL CORP. /NY/ TURN · Entity 75342 | PurchaseCommon Stock | 677 | $7.37 | $4,989.49 |
DisclosureSEC source: 0001268528-21-000004 · wf-form4_161728225670022.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,585 Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 09:07 UTC | 180 DEGREE CAPITAL CORP. /NY/ TURN · Entity 75342 | PurchaseCommon Stock | 1,365 | $7.32 | $9,993.85 |
DisclosureSEC source: 0001268528-21-000002 · wf-form4_161581363173158.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,908 F1 · balance_after: Total amount of securities beneficially owned reflects 1-for-3 reverse stock split effected on December 31, 2020. Read SEC document |
| December 30, 2020 Filed Dec 31, 2020 08:46 UTC | 180 DEGREE CAPITAL CORP. /NY/ TURN · Entity 75342 | PurchaseCommon Stock | 4,629 | $2.16 | $9,995.86 |
DisclosureSEC source: 0001268528-20-000010 · wf-form4_160942240372203.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,629 Read SEC document |
| October 15, 2020 Filed Oct 20, 2020 19:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002078 · primary_01.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,200 shares Expires 2020-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 15, 2019. F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020. F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020. Read SEC document |
| October 15, 2020 Filed Oct 20, 2020 19:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 2,200 | $10.36 | $22,792.00 |
DisclosureSEC source: 0001593968-20-002078 · primary_01.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,237 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:20 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-008844 · wf-form4_159113640785087.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 Underlying: Common Stock · 8,303 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-008620 · wf-form4_159078144063561.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2019. F3 · derivative.exercise_date: The restricted stock units vested on May 28, 2020 F3 · derivative.expiration_date: The restricted stock units vested on May 28, 2020 Read SEC document |
| May 28, 2020 Filed May 29, 2020 19:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 6,000 | $10.99 | $65,940.00 |
DisclosureSEC source: 0001628280-20-008620 · wf-form4_159078144063561.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,037 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 19:11 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 3,333 | $9.01 Strike: $9.01 | $30,030.33 |
DisclosureSEC source: 0001628280-19-014186 · wf-form4_157375868036736.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2019-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 19:11 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 3,333 | $9.01 | $30,030.33 |
DisclosureSEC source: 0001628280-19-014186 · wf-form4_157375868036736.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 19:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 2,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-012377 · wf-form4_157133990593311.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Underlying: Common Stock · 2,200 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007415 · wf-form4_155926319042775.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,240 shares Expires 2019-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 30, 2018. F3 · derivative.exercise_date: The restricted stock units vested on May 30, 2019. F3 · derivative.expiration_date: The restricted stock units vested on May 30, 2019. Read SEC document |
| May 30, 2019 Filed May 31, 2019 00:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,240 | $9.91 | $42,018.40 |
DisclosureSEC source: 0001628280-19-007415 · wf-form4_155926319042775.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 28, 2019 Filed May 31, 2019 00:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Units (RSU) · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-19-007415 · wf-form4_155926319042775.xml · derivative · entry 3 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 24, 2019 Filed May 29, 2019 01:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonstatutory Stock Option (Right to Buy) · Derivative | 3,334 | $0.00 Strike: $9.01 | $0.00 |
DisclosureSEC source: 0001628280-19-007279 · wf-form4_155909492002250.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 3,334 shares Expires 2019-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2019 Filed May 29, 2019 01:55 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 3,334 | $9.01 | $30,039.34 |
DisclosureSEC source: 0001628280-19-007279 · wf-form4_155909492002250.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-011099 · rdgdoc.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,240 Underlying: Common Stock · 4,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 4,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010772 · rdgdoc.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,286 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2017. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:38 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 4,286 | $13.65 | $58,503.90 |
DisclosureSEC source: 0001437749-18-010772 · rdgdoc.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 23:30 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 4,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-010674 · rdgdoc.xml · derivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,286 Underlying: Common Stock · 4,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 5,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-010192 · rdgdoc.xml · derivative · entry 2 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,282 shares Expires 2017-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on May 25, 2017. F3 · derivative.expiration_date: The restricted stock units vested on May 25, 2017. Read SEC document |
| May 25, 2017 Filed May 26, 2017 23:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 5,282 | $13.50 | $71,307.00 |
DisclosureSEC source: 0001437749-17-010192 · rdgdoc.xml · nonDerivative · entry 1 PANKOPF TONIA L · CIK 0001268528 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.